abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

23 Oct 2001

Author:
Tom Cohen, Associated Press, in San Francisco Chronicle

Canadian government agrees to buy anti-anthrax drug from patent holder Bayer in an emergency

The Canadian government, working to avoid a patent lawsuit by Bayer, agreed to rely on the pharmaceutical giant to supply the anti-anthrax drug Cipro and only use generic drugs if the company can't deliver. Bayer has provided 200,000 free Cipro tablets for front-line workers and has promised to deliver more for $1.30 per pill within two days of an attack. If the German-based company can't deliver, then Health Canada would be free to use its stockpiled generic drug.